Kelly Seo
Research Associate, Department of Public Health and Primary Care
Cambridge University, United Kingdom
Kelly Seo (also known as Mikyung Kelly Seo), PhD in health economics, and is a health economist currently working at the Cambridge Research Methods Hub (CRMH) (https://www.phpc.cam.ac.uk/pcu/research/research-groups/crmh) and Imperial College London for the NIHR London In Vitro Diagnostics Co-operative (https://www.imperial.ac.uk/medicine/research-and-impact/groups/livd/). She is an experienced health economist, having worked for international organisations (International Labour Organisation (ILO, Geneva) and the International Vaccine Institute (IVI, Seoul)) and HEOR consultancies. She holds a PhD in health economics from the London School of Hygiene and Tropical Medicine (LSHTM). Her PhD thesis was on economic evaluations of companion biomarkers for targeted therapies in cancer. She also holds an MSc in health policy, planning and financing from the London School of Economics (LSE) and LSHTM.
Economic evaluations, Discrete choice experiment (DCE), Decision-analytic modelling, Health technology assessment (HTA), Survival analysis, Care pathway analysis, Value of information analysis, Econometrics, Systematic literature review and meta-analysis, Budget impact analysis
Pharmacoeconomics: Open Access received 106 citations as per Google Scholar report